823189-68-0 Usage
General Description
5-Pyrimidinecarboxamide, N-methoxy-N-methyl- is a chemical compound with the molecular formula C7H8N4O2. It is a derivative of pyrimidinecarboxamide, containing both a methoxy and a methyl group. 5-Pyrimidinecarboxamide, N-methoxy-N-methyl- is used in the pharmaceutical industry as a building block for the synthesis of various drugs and pharmaceuticals. It is also used as a research chemical in scientific studies and experiments. The presence of both methoxy and methyl groups in this compound makes it an important intermediate for the preparation of numerous bioactive molecules. Overall, 5-Pyrimidinecarboxamide, N-methoxy-N-methyl- has significant potential applications in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 823189-68-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,2,3,1,8 and 9 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 823189-68:
(8*8)+(7*2)+(6*3)+(5*1)+(4*8)+(3*9)+(2*6)+(1*8)=180
180 % 10 = 0
So 823189-68-0 is a valid CAS Registry Number.
823189-68-0Relevant articles and documents
METALLOENZYME INHIBITOR COMPOUNDS AS FUNGICIDES
-
Paragraph 00245, (2015/11/09)
The instant invention describes compounds of Formula I having metalloenzyme modulating activity, and methods of treating diseases disorders or symptoms thereof mediated by such metalloenzymes.
HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
-
Paragraph 0342; 0343, (2014/05/07)
The present invention comprises compounds of Formula I. wherein: R1, R2, R3, R4, R5, R6, R7, R8, and R9 are defined in the specification. The invention also comprises a method of treating or ameliorating a syndrome, disorder or disease, wherein said syndrome, disorder or disease is rheumatoid arthritis or psoriasis. The invention also comprises a method of modulating RORγt activity in a mammal by administration of a therapeutically effective amount of at least one compound of claim 1.
TACHYKININ RECEPTOR ANTAGONISTS
-
Page 54, (2010/02/10)
The present invention relates to selective NK-1 receptor antagonists of Formula (I) or a pharmaceutically acceptable salt thereof, for the treatment of disorders associated with an excess of tachykinins.
